Taddeo Regina L, Moser Joanne T, Minnock Pantea P
Diabetes Center for Children at The Children's Hospital of Philadelphia, 34th Street and Civic Center Blvd, Philadelphia, PA 19342, USA.
Pediatr Endocrinol Rev. 2017 Jun;14(Suppl 2):435-440. doi: 10.17458/per.vol14.2017.tmm.glucosemonitoring.
Continuous Glucose Monitoring (CGM) is rapidly becoming a standard of care in the management of Type 1 diabetes (T1D). Today's devices are nearly as accurate as home glucose meters. They provide glucose data every 5 minutes, alert to high and low blood glucose levels, and allow for remote monitoring of a user's glucose data and patterns. Use of CGM has many benefits including support for tighter glycemic control without increasing the risk for hypoglycemia. There is however emerging evidence of some negative aspects associated with using CGM, which may result in decreased utilization of the device as well as a decline in quality of life, especially in the pediatric population. This article explores some of the challenges to successful CGM use and offers guidelines for helping patients/families minimize the negative impact of these revolutionary devices.
连续血糖监测（CGM）正迅速成为1型糖尿病（T1D）管理中的一种护理标准。如今的设备几乎与家用血糖仪一样准确。它们每5分钟提供一次血糖数据，对高血糖和低血糖水平发出警报，并允许远程监测用户的血糖数据和模式。使用CGM有许多好处，包括支持更严格的血糖控制而不增加低血糖风险。然而，有新出现的证据表明使用CGM存在一些负面影响，这可能导致该设备的使用率下降以及生活质量下降，尤其是在儿科人群中。本文探讨了成功使用CGM的一些挑战，并提供了帮助患者/家庭将这些革命性设备的负面影响降至最低的指导方针。
